1-1 of 1
Michael R Moore, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Romiplostim in Patients with Low or Intermediate-Risk Myelodysplastic Syndrome (MDS) Receiving Decitabine.

Peter L Greenberg, MD, Guillermo Garcia-Manero, MD, Michael R Moore, MD, Lloyd E. Damon, MD, Gail J. Roboz, MD, Helen Wei, Hagop Kantarjian, MD, Janet L. Franklin, MD, MPH
Journal: Blood
Blood (2009) 114 (22): 1769.
https://doi.org/10.1182/blood.V114.22.1769.1769
Published: 2009